subject: Clinical Research In London Or Possible Outsourcing To Developing Countries [print this page] The increase in prices of chemical substances along with volunteer payment for clinical trial activities has ensured that clinical research work needs to be outsourced to developing countries like India or China. This is because new pharmaceutical strategies are mainly dependant on research and developmental activities that can be extremely costly in London. The clinical research activities which was around 10% of the operating cost earlier in London has slowly gone up to 15 to 20% over the years. The annual budget allocation for research activities has also gone up in a significant manner. This makes it impossible to sell these new drugs at cheaper rates in the UK market.
In spite of the fact that London is home to some of the best pharmaceutical research organisations there has been a need to shift clinical research activities to developing nations. This has led to countries like China and India getting hold of bulk of clinical research activities. Once this is done the rise in costs related to research activities as in London does not seem to have a similar effect on revenues due to low cost research possibilities in these countries. The main reason being that these countries are situated in low currency valuation regions of the world.
Along with cost advantage, these clinical research activities have now started to offer quality in terms of research being done. The population of these countries allows rapid response in terms of clinical trials associated with the new drug. All the necessary guidelines as necessary to be followed for these clinical research activities are adhered to while conducting clinical research activities in these countries.
